T. Rowe Price Associates’s Zimmer Biomet ZBH Stock Holding History

T. Rowe Price Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$723M	Sell	7,999,712 -5,632,107	-41%	-$517M	0.08%	190
2025 Q4	$1.23B	Sell	13,631,819 -1,450,619	-10%	-$138M	0.13%	136
2025 Q3	$1.49B	Buy	15,082,438 +285,834	+2%	+$28.3M	0.16%	115
2025 Q2	$1.35B	Buy	14,796,604 +339,742	+2%	+$32.9M	0.15%	131
2025 Q1	$1.64B	Sell	14,456,862 -303,582	-2%	-$32.5M	0.2%	96
2024 Q4	$1.56B	Buy	14,760,444 +176,337	+1%	+$18.9M	0.18%	107
2024 Q3	$1.57B	Buy	14,584,107 +2,078,774	+17%	+$227M	0.18%	107
2024 Q2	$1.36B	Buy	12,505,333 +1,862,532	+18%	+$220M	0.16%	123
2024 Q1	$1.4B	Buy	10,642,801 +1,215,935	+13%	+$152M	0.17%	126
2023 Q4	$1.15B	Buy	9,426,866 +1,458,359	+18%	+$163M	0.15%	141
2023 Q3	$894M	Sell	7,968,507 -1,254,625	-14%	-$159M	0.13%	163
2023 Q2	$1.34B	Sell	9,223,132 -1,208,907	-12%	-$164M	0.19%	107
2023 Q1	$1.35B	Sell	10,432,039 -768,070	-7%	-$96.4M	0.2%	106
2022 Q4	$1.43B	Buy	11,200,109 +650,886	+6%	+$75.5M	0.23%	94
2022 Q3	$1.1B	Buy	10,549,223 +1,619,881	+18%	+$178M	0.18%	113
2022 Q2	$938M	Buy	8,929,342 +1,062,625	+14%	+$126M	0.12%	190
2022 Q1	$1.01B	Sell	7,866,717 -562,745	-7%	-$67.8M	0.1%	205
2021 Q4	$1.04B	Buy	8,429,462 +424,878	+5%	+$55.6M	0.09%	215
2021 Q3	$1.14B	Buy	8,004,584 +1,767,259	+28%	+$260M	0.11%	195
2021 Q2	$974M	Buy	6,237,325 +956,272	+18%	+$155M	0.09%	233
2021 Q1	$821M	Sell	5,281,053 -676,071	-11%	-$105M	0.08%	252
2020 Q4	$891M	Sell	5,957,124 -762,610	-11%	-$108M	0.09%	234
2020 Q3	$888M	Buy	6,719,734 +288,176	+4%	+$37.6M	0.1%	208
2020 Q2	$745M	Sell	6,431,558 -296,911	-4%	-$34.2M	0.09%	222
2020 Q1	$660M	Buy	6,728,469 +398,568	+6%	+$52.2M	0.1%	207
2019 Q4	$920M	Sell	6,329,901 -111,449	-2%	-$15.4M	0.12%	188
2019 Q3	$858M	Buy	6,441,350 +205,520	+3%	+$26.5M	0.12%	189
2019 Q2	$713M	Buy	6,235,830 +182,316	+3%	+$21.4M	0.1%	215
2019 Q1	$751M	Buy	6,053,514 +637,671	+12%	+$72.5M	0.11%	198
2018 Q4	$545M	Buy	5,415,843 +2,438,555	+82%	+$274M	0.09%	220
2018 Q3	$380M	Buy	2,977,288 +523,715	+21%	+$62.3M	0.06%	332
2018 Q2	$265M	Buy	2,453,573 +634,928	+35%	+$69.1M	0.04%	399
2018 Q1	$193M	Buy	1,818,645 +112,910	+7%	+$13.1M	0.03%	470
2017 Q4	$200M	Buy	1,705,735 +38,622	+2%	+$4.37M	0.03%	462
2017 Q3	$190M	Buy	1,667,113 +190,667	+13%	+$22M	0.03%	459
2017 Q2	$184M	Sell	1,476,446 -6,518	-0.4%	-$773K	0.03%	458
2017 Q1	$176M	Buy	1,482,964 +87,827	+6%	+$9.95M	0.03%	456
2016 Q4	$140M	Buy	1,395,137 +945,460	+210%	+$101M	0.03%	502
2016 Q3	$56.8M	Buy	449,677 +83,306	+23%	+$10.3M	0.01%	768
2016 Q2	$42.8M	Buy	366,371 +28,164	+8%	+$3.19M	0.01%	845
2016 Q1	$35M	Buy	338,207 +22,866	+7%	+$2.21M	0.01%	902
2015 Q4	$31.4M	Sell	315,341 -21,372	-6%	-$2.09M	0.01%	937
2015 Q3	$30.7M	Sell	336,713 -2,771	-0.8%	-$278K	0.01%	950
2015 Q2	$36M	Buy	339,484 +16,357	+5%	+$1.81M	0.01%	948
2015 Q1	$36.9M	Buy	323,127 +19,982	+7%	+$2.28M	0.01%	933
2014 Q4	$33.4M	Buy	303,145 +9,980	+3%	+$1.05M	0.01%	978
2014 Q3	$28.6M	Buy	293,165 +1,236	+0.4%	+$122K	0.01%	1020
2014 Q2	$29.4M	Buy	291,929 +14,832	+5%	+$1.45M	0.01%	1018
2014 Q1	$25.4M	Sell	277,097 -194,876	-41%	-$18M	0.01%	1048
2013 Q4	$42.7M	Sell	471,973 -266,399	-36%	-$23.1M	0.01%	888
2013 Q3	$58.9M	Sell	738,372 -63,907	-8%	-$5.03M	0.01%	757
2013 Q2	$58.4M	Buy	+802,279	New	+$60M	0.02%	734